日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Non-diabetic Kidney Disease in Type 2 Diabetes: From Kidney Biopsy to Precision Medicine

2型糖尿病非糖尿病性肾病:从肾活检到精准医疗

Sreedharan, Sreenath; M K, Mohandas; K B, Vismaya; Raju, Nikhil

Chronic Renal Vein Thrombosis With Preserved Renal Function Due to Protein S Deficiency: A Diagnostic Challenge in a Resource-Limited Setting

蛋白S缺乏引起的慢性肾静脉血栓形成伴肾功能保留:资源匮乏环境下的诊断挑战

Sreedharan, Sreenath; M K, Mohandas; K B, Vismaya; Raju, Nikhil

CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy

CD19-CD28:一种亲和力优化的CD28激动剂,可与glofitamab(CD20-TCB)联合使用,作为现成的免疫疗法。

Sam, Johannes; Hofer, Thomas; Kuettel, Christine; Claus, Christina; Thom, Jenny; Herter, Sylvia; Georges, Guy; Korfi, Koorosh; Lechmann, Martin; Eigenmann, Miro Julian; Marbach, Daniel; Jamois, Candice; Lechner, Katharina; Krishnan, Sreenath M; Gaillard, Brenda; Marinho, Joana; Kronenberg, Sven; Kunz, Leo; Wilson, Sabine; Briner, Stefanie; Gebhardt, Samuel; Varol, Ahmet; Appelt, Birte; Nicolini, Valeria; Speziale, Dario; Bez, Miriam; Bommer, Esther; Eckmann, Jan; Hage, Carina; Limani, Florian; Jenni, Silvia; Schoenle, Anne; Le Clech, Marine; Vallier, Jean-Baptiste Pierre; Colombetti, Sara; Bacac, Marina; Gasser, Stephan; Klein, Christian; Umaña, Pablo

A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer

用于学习肿瘤药物剂量反应的多状态建模和仿真框架:以非小细胞肺癌中的bintrafusp alfa为例

Liu, Han; Milenković-Grišić, Ana-Marija; Krishnan, Sreenath M; Jönsson, Siv; Friberg, Lena E; Girard, Pascal; Venkatakrishnan, Karthik; Vugmeyster, Yulia; Khandelwal, Akash; Karlsson, Mats O

Bayesian forecasting of tumor size metrics and overall survival

肿瘤大小指标和总体生存率的贝叶斯预测

Krishnan, Sreenath M; Friberg, Lena E

The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease

酪氨酸激酶抑制剂尼达尼布可改善常染色体显性多囊肾病

Abeda Jamadar, Sreenath M Suma, Sijo Mathew, Timothy A Fields, Darren P Wallace, James P Calvet, Reena Rao

Tumor growth inhibition modeling of individual lesion dynamics and interorgan variability in HER2-negative breast cancer patients treated with docetaxel

多西他赛治疗HER2阴性乳腺癌患者的肿瘤生长抑制模型:个体病灶动态和器官间变异性

Krishnan, Sreenath M; Laarif, Sofiene S; Bender, Brendan C; Quartino, Angelica L; Friberg, Lena E

Multistate model for pharmacometric analyses of overall survival in HER2-negative breast cancer patients treated with docetaxel

多状态模型用于对接受多西他赛治疗的 HER2 阴性乳腺癌患者的总生存期进行药代动力学分析

Krishnan, Sreenath M; Friberg, Lena E; Bruno, René; Beyer, Ulrich; Jin, Jin Y; Karlsson, Mats O